Engineering and physiology synthesis for equipment selection. This is not clinical protocol guidance. Treatment FiO₂ targets, pressure, and attendant requirements should follow recognized UHMS/ECHM standards for the specific indication.

View chambersAsk about specifications

What FiO₂ is, and why it matters

FiO₂ means fraction of inspired oxygen: the proportion of the gas you actually breathe that is oxygen, written as a decimal. Room air is about 0.21, or 21% oxygen. The maximum oxygen fraction achievable without pressure is 1.0, or 100%; delivering a higher oxygen pressure than room conditions allow is exactly what a hyperbaric chamber is built to do.

FiO₂ describes the gas mix at the airway, not how compressed it is. The oxygen fraction of air stays about 21% regardless of barometric pressure or altitude. Pressure changes the total pressure, not the fraction. That distinction matters because the therapeutic oxygen dose in hyperbaric therapy follows, in practical terms, this relationship:

Inspired oxygen pressure (PiO₂) approximately equals (chamber pressure minus water-vapor pressure) multiplied by FiO₂At 2.4 ATA with FiO₂ 1.0: (2.4 x 760 – 47) x 1.0 is about 1,777 mmHg.

That inspired oxygen pressure, not the pressure reading alone and not the word "oxygen" on a label, is the quantity HBOT physiology references connect to mechanisms such as raised dissolved oxygen content, angiogenesis, fibroblast and collagen activity, and antimicrobial effect.

Because the relationship is multiplicative, the dose scales linearly with FiO₂. A device delivering FiO₂ 0.85 instead of 1.0 supplies roughly 85% of the intended oxygen dose at the same pressure. Unlike pressure, which every operator can see on a gauge, delivered FiO₂ is invisible unless it is measured at the airway. That measurement gap is where most equipment-selection confusion begins.

Evidence-grade note: The first three rows are hyperbaric-specific, and the HBOT-direct rows are qualitative. There does not appear to be a clean modern distribution study of chamber BIBS demand-mask delivered FiO₂ at treatment pressure. The percentage penalties come from normobaric mask and NIV bench data, which transfer mechanistically because the relevant leak physics are the same: chamber or room air is entrained on inhalation past an imperfect seal. The strongest honest claim is mechanistic plus analog, not a hyperbaric RCT.

What to be wary of in BIBS-mask and mild-chamber models

If you are evaluating a soft-shell or mild chamber that pressurizes with air and delivers oxygen through a concentrator plus BIBS mask, these are the failure points that quietly reduce the delivered dose.

1. The source gas is not 100% to begin with. WHO medical-oxygen guidance and PSA oxygen-concentrator behavior put concentrator oxygen around the 90% to 96% range, commonly near 93% +/- 3%. Before any mask leak occurs, the source ceiling is already below 1.0.
2. Concentrator purity falls as flow rises. Running a concentrator near or past its rated flow can reduce purity. A BIBS mask inherits whatever the concentrator is producing at that moment, which is rarely measured in wellness deployments.
3. The mask seal is the dominant uncontrolled variable. Beards, facial structure, talking, comfort adjustments, pediatric movement, and work of breathing can all entrain ambient air on inhalation. The HBOT-direct comparison found demand masks reached acceptable FiO₂ only when trained staff supervised the seal.
4. Delivered FiO₂ is usually assumed, not measured. Preoxygenation data shows oxygen-delivery devices can substantially overestimate true end-tidal oxygen, with loose-fitting devices overestimating the most.
5. Mild chambers stack two discounts. A low pressure setting, often around 1.3 ATA, multiplied by sub-1.0 concentrator oxygen through a leak-prone mask can put inspired PO₂ at a fraction of a 2.4 ATA / FiO₂ 1.0 clinical dose.
6. "100% oxygen" claims rarely survive contact with the airway. A 90% to 96% source multiplied by an imperfect seal does not deliver 1.0 FiO₂. Treat the phrase as a marketing input until delivered FiO₂ is measured.
7. Reverse leak is a safety issue, not just a dose issue. Exhaled oxygen leaking past a high-resistance mask into the cabin can raise chamber oxygen concentration and fire risk, which is one reason hoods and well-designed regulators exist.

Bottom line for equipment selection

If the goal is the physiological dose the clinical literature is built on, the money is usually better spent on access to a true 100% oxygenated model: a monoplace chamber filled with oxygen, or a multiplace chamber using a continuously ventilated hood with verified FiO₂, at a facility following recognized protocols.

The mild-chamber model has legitimate uses around accessibility, cost, comfort, and operational simplicity. Some buyers choose it deliberately for those reasons. It should be chosen with a clear understanding that it is not the same oxygen dose, and that the gap between nameplate oxygen and delivered oxygen is real, measurable in principle, and often unmeasured in practice.

If dose certainty is what you are paying for, pay for the 100% model.

Sources

1. UHMS, Indications for Hyperbaric Oxygen Therapy.
2. StatPearls / NCBI Bookshelf, Oxygen Administration.
3. CU Anschutz, Rules on Oxygen Therapy: Physiology.
4. Medscape, Hyperbaric Oxygen Therapy: Overview, Physics and Physiology.
5. Stephenson RN, Mackenzie I, Watt SJ, Ross JA. Measurement of oxygen concentration in delivery systems used for hyperbaric oxygen therapy. Undersea Hyperb Med. 1996;23(3):185-188.
6. Preoxygenation end-tidal oxygen study, Annals of Emergency Medicine article and NCT03840486 trial record.
7. BMC Research Notes, Leaks can dramatically decrease FiO₂ on home ventilators: a bench study.
8. JFD / Divex, Ultralite 2 BIBS Mask chamber-gas leak trials.
9. Scientific Reports, Flexible oxygen concentrators for medical applications.
10. Oxygen Plus Medical, Oxygen purity percentage vs. flow rate.